NQ PE Project Stingray Parent
Raleigh, US · Founded 2020
Biotech
Founders & leadership
JE
Jeffrey EdwardsDirector of the GP.
EA
E. Ashton PooleDirector of the GP.
Reported raises · per SEC filings
Form D private placements▶$11.4MraisedSep 2022 · 4 investors · PharmaceuticalsRule 506(b)
▶$11.4MraisedSep 2022 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey EdwardsDirector
- "(the ""GP"")" NQ PE Project Stingray Parent GP, Ltd.Executive Officer
- E. Ashton PooleDirector
- Offering amount
- $16.2M
- Amount sold
- $11.4M
- First sale
- Sep 2022
- Incorporated
- Limited Partnership, Cayman Islands, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.